Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nature reviews: Gastroenterology & hepatology

• Publication date

  2022-02-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41575-021-00566-7PMID 35165436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Overview of the Problem

  2021cited by this paper
• Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content.

  2020cited by this paper
• Bile acids mediate signaling between microbiome and the immune system

  2020cited by this paper
• Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

  2020cited by this paper
• Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results

  2020cited by this paper
• From basic research to clinical application of γδ T cells

  2020cited by this paper
• Bacterial metabolism of bile acids promotes peripheral Treg cell generation

  2020cited by this paper
• The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids

  2020cited by this paper
• A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

  2020cited by this paper
• Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders

  2020cited by this paper
• The Commensal Microbe V eillonella as a Marker for Response to an FGF19 Analog in NASH

  2020cited by this paper
• Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

  2020cited by this paper
• FXR mediates T cell-intrinsic responses to reduced feeding during infection

  2020cited by this paper
• A guide to plasma membrane solute carrier proteins

  2020cited by this paper
• Cholangitis Lenta: What Hepatologists Need to Know

  2020cited by this paper
• Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.

  2020cited by this paper
• Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

  2020cited by this paper
• NASH-related increases in plasma bile acid levels depend on insulin resistance

  2020cited by this paper
• Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression

  2019cited by this paper
• The Pyrin Inflammasome in Health and Disease

  2019cited by this paper
• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

  2019cited by this paper
• Emerging roles of bile acids in mucosal immunity and inflammation

  2019cited by this paper
• Contributing factors and outcomes of burn-associated cholestasis.

  2019cited by this paper
• Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.

  2019cited by this paper
• The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

  2019cited by this paper
• Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.

  2019cited by this paper
• A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

  2019cited by this paper
• Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis

  2019cited by this paper
• Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review

  2019cited by this paper
• Liver Injury and Failure in Critical Illness

  2019cited by this paper
• FGF19–FGFR4 Signaling in Hepatocellular Carcinoma

  2019cited by this paper
• Bile acid analogues are activators of pyrin inflammasome

  2019cited by this paper
• NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

  2019cited by this paper
• Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.

  2019cited by this paper
• Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis

  2018cited by this paper
• Open: Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial

  2018cited by this paper
• Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice

  2018cited by this paper
• Bile acid metabolites control Th17 and Treg cell differentiation

  2018cited by this paper
• Effect of NGM 282 , a FGF 19 analogue , in Primary Sclerosing Cholangitis : a Multicentre , Randomized , Double-Blind , Placebo-Controlled Phase 2 Trial

  2018cited by this paper
• A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

  2018cited by this paper
• The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

  2018cited by this paper
• Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas

  2018cited by this paper
• Bile Acids Activated Receptors Regulate Innate Immunity

  2018cited by this paper
• Role of bile acids in colon carcinogenesis

  2018cited by this paper
• Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies

  2018cited by this paper
• Role of TGR5 (GPBAR1) in Liver Disease

  2018cited by this paper
• Bile acids in nonalcoholic steatohepatitis: Pathophysiological driving force or innocent bystanders?

  2018cited by this paper
• NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

  2018cited by this paper
• Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH

  2018cited by this paper
• NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

  2018cited by this paper
• norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

  2017cited by this paper
• Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.

  2017cited by this paper
• A Comprehensive Review

  2017cited by this paper
• Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD

  2017cited by this paper
• Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.

  2017cited by this paper
• Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.

  2017cited by this paper
• Role of early growth response 1 in liver metabolism and liver cancer

  2017cited by this paper
• The ascending pathophysiology of cholestatic liver disease

  2017cited by this paper
• A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

  2017cited by this paper
• The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis

  2017cited by this paper
• Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance.

  2017cited by this paper
• Lithocholic Acid Stimulates IL‐8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity

  2017cited by this paper
• Systematic review and meta-analysis.

  2017cited by this paper
• Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects

  2017cited by this paper
• New therapeutic concepts in bile acid transport and signaling for management of cholestasis

  2017cited by this paper
• Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis

  2016cited by this paper
• Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

  2016cited by this paper
• Bile Acid‐Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes

  2016cited by this paper
• Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis

  2016cited by this paper
• Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

  2016cited by this paper
• Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis.

  2016cited by this paper
• Novel bile acid therapeutics for the treatment of chronic liver diseases

  2016cited by this paper
• Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

  2016cited by this paper
• Pharmacological inhibition of apical sodium‐dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice

  2016cited by this paper
• Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect

  2016cited by this paper
• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

  2016cited by this paper
• Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans[S]

  2016cited by this paper
• Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells

  2016cited by this paper
• Microbiota-induced obesity requires farnesoid X receptor

  2016cited by this paper
• Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.

  2016cited by this paper
• Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease

  2016cited by this paper
• Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

  2016cited by this paper
• Farnesoid X Receptor Inhibits Glucagon-Like Peptide-1 Production by Enteroendocrine L-cells

  2015cited by this paper
• Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

  2015cited by this paper
• Bile acid receptors and nonalcoholic fatty liver disease.

  2015cited by this paper
• New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

  2015cited by this paper
• The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid

  2015cited by this paper
• TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro

  2015cited by this paper
• Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors

  2015cited by this paper
• Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation

  2015cited by this paper
• Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?

  2015cited by this paper
• Sphingosine‐1‐phosphate receptor 2: A novel bile acid receptor and regulator of hepatic lipid metabolism?

  2015cited by this paper
• Cholestatic liver (dys)function during sepsis and other critical illnesses

  2015cited by this paper
• Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy

  2015cited by this paper
• A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism.

  2015cited by this paper
• TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?

  2015cited by this paper
• Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).

  2015cited by this paper
• GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

  2015cited by this paper
• Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

  2015cited by this paper
• Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.

  2015cited by this paper

• The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis

  2026cites this paper
• Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases.

  2026cites this paper
• Analysis of gut microbiota and intestinal secondary bile acids metabolism in rats after short-term antibiotic treatment.

  2026cites this paper
• Microbially produced bile acids are associated with increased IgG autoantibodies and poorer mental wellbeing in fibromyalgia

  2026cites this paper
• Bile acids and gut microbiota: interactions and impacts on polycystic ovary syndrome

  2026cites this paper
• Association between cholecystectomy/gallbladder pathology and colorectal polyps: a systematic review and meta-analysis

  2026cites this paper
• Regulated cell death in sepsis-associated liver injury: molecular mechanisms and therapeutic implications.

  2026cites this paper
• Genome-resolved analysis of bile acid-metabolizing microbiota in Tibetan antelope (Pantholops hodgsonii).

  2026cites this paper
• Gut microbiome in biliary atresia

  2026cites this paper
• Yu Dan Tong Formula inhibits NLRP3 inflammasome activation by suppressing Ca²⁺ influx in treating cholestatic liver disease.

  2026cites this paper
• Polystyrene nanoplastics readily penetrate intestine and cause sex-specific effects mediated by bile acids and microbiome.

  2026cites this paper
• Role of gut microbiota metabolites in maintaining intestinal health and preventing weaning-associated diarrhea in piglets

  2026cites this paper
• Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway

  2026cites this paper
• Maternal supplementation of functional fiber improves reproduction performance by modulating gut microbiota during pregnancy

  2026cites this paper
• Development of an analytical method for simultaneous determination of 38 bile acids and its application in studying the mechanism of WuZhi Pian against rifampicin-induced liver injury

  2026cites this paper
• Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal.

  2026cites this paper
• Xiayuxue decoction alleviates MASH by regulating gut microbiota, bile acid metabolism, and m6A modification.

  2026cites this paper
• Capsaicin Improves Lipid Metabolism Disorders Caused by LPS-Induced Immune Stress in Weaned Piglets.

  2026cites this paper
• Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance.

  2026cites this paper
• Untargeted Serum Metabolomics Reveals Differential Signatures in Gallstone-Associated and Gallstone-Free Gallbladder Cancer Variants.

  2026cites this paper
• Mechanisms and advantages of natural derived small molecule compounds in the prevention and treatment of colorectal cancer: a review

  2025cites this paper
• Taurine alleviated paraquat-induced oxidative stress and gut-liver axis damage in weaned piglets by regulating the Nrf2/Keap1 and TLR4/NF-κB signaling pathways

  2025cites this paper
• 7‐Ketodeoxycholic Acid Promotes Colonic Mucosal Healing by Inducing Calcium Release from Endoplasmic Reticulum via the TGR5‐IP3R Pathway

  2025cites this paper
• Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease

  2025cites this paper
• Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome

  2025cites this paper
• Bidirectional crosstalk of the gut-liver axis in metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Gut microbiota as a metabolic mediator to prevent or attenuate MASLD

  2025cites this paper
• Unveiling Gastrointestinal Involvement in Hypopituitarism: Clinical Features and Treatment Approaches

  2025cites this paper
• Dark tea ameliorates liver fibrosis via FXR/TGR5-mediated intestinal permeability and liver sinusoidal capillarization.

  2025cites this paper
• Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions

  2025cites this paper
• Cholesterol in the CNS: functions, recycling and remyelination

  2025cites this paper
• Huaganjian decoction ameliorates metabolic dysfunction-associated steatotic liver disease through liver-gut crosstalk.

  2025cites this paper
• Unveiling the gut's plastic predicament: How micro- and nano-plastics drive distinct toxicological pathways in Enchytraeus crypticus.

  2025cites this paper
• Identification of gut microbial bile acid metabolic enzymes via an AI-assisted pipeline.

  2025cites this paper
• Bile acid signaling in MASLD: from pathogenesis to therapeutic applications.

  2025cites this paper
• Recent investigation of the medicinal plants’ effectiveness in the natural management of urinary and gallstones: a review

  2025cites this paper
• Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects.

  2025cites this paper
• Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy

  2025cites this paper
• A preliminary study of serum metabolomic profiling in male patients with acute brucellosis

  2025cites this paper
• Efficacy and mechanism of iridoid glycosides from Gentianella turkestanorum (Gand.) Holub on non-alcoholic steatohepatitis based on RNA sequencing.

  2025cites this paper
• Cholestasis in Alcohol-Associated Liver Disease

  2025cites this paper
• Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity.

  2025cites this paper
• Hepatoprotective Effects of Dandelion against AFB1-induced Liver Injury are Associated with Activation of Bile Acid-FXR Signaling in Chicks.

  2025cites this paper
• A novel therapy targeting the gut–liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium

  2025cites this paper
• Drug-endobiotic interaction effect of UGT enzymes inhibition on systemic bile acids levels in rat

  2025cites this paper
• Phenolic Ethanolic Extracts of Specialty Sorghum Ameliorate Intestinal Colitis and Inflammation Induced by Dextran Sulfate Sodium in Mice

  2025cites this paper
• Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis

  2025cites this paper
• Microbiome and metabolome association network analysis identifies Clostridium_sensu_stricto_1 as a stronger keystone genus candidate than Bifidobacterium in the gut of common marmosets

  2025cites this paper
• Machine Learning based Model Reveals the Metabolites Involved in Coronary Artery Disease

  2025cites this paper
• Pretreatment serum bile acid composition and predictability of subsequent response to odevixibat in patients with bile salt export pump (BSEP) deficiency.

  2025cites this paper
• Bupleuri Radix polysaccharides enhance the efficacy and intestinal absorption of baicalin via regulating intestinal β-glucuronidase activity in MASH mice.

  2025cites this paper
• Bile Acid-Mediated Interactions with Various Cell Types in the Cholestatic Liver

  2025influential citation
• Disrupted bilirubin metabolism and gut microbiome dysregulation: A link to cardio-renal-hepatic-metabolic health in obstructive sleep apnea.

  2025cites this paper
• E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.

  2025cites this paper
• Agrimonolide from Agrimonia pilosa Ledeb attenuates cholestatic liver injury and macrophage infiltration via the inhibition of bile acid excretion transporters.

  2025cites this paper
• The particle drifting effect in vivo: impact of dose and animal species.

  2025cites this paper
• Microbiota-derived bile acid metabolic enzymes and their impacts on host health

  2025influential citation
• FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity.

  2025cites this paper
• Dendrobium officinale polysaccharide relieves hepatointestinal damage induced by chronic arsenic exposure in chickens by regulating gut microbiota.

  2025cites this paper
• Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis

  2025cites this paper
• Tauroursodeoxycholic acid modulates neuroinflammation via STING/NF-κB inhibition after traumatic brain injury.

  2025cites this paper
• Bile Acids and Bile Acid Metabolites in the Activation and Inhibition of Pyroptotic Cell Death, Influencing Inflammation

  2025cites this paper
• Pangenome Analysis of Clostridium scindens: A Collection of Diverse Bile Acid- and Steroid-Metabolizing Commensal Gut Bacterial Strains

  2025cites this paper
• Advances in gut-lung axis research: clinical perspectives on pneumonia prevention and treatment

  2025cites this paper
• The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity

  2025cites this paper
• Compositional and Metabolomic Shifts of the Gut Microbiome in Alcohol‐Related Liver Disease

  2025cites this paper
• Qingre Sanjie Formula alleviates atherosclerosis by promoting LXR-α/ABCG5/G8-mediated reverse cholesterol transport and bile acid synthesis.

  2025cites this paper
• Fluorofenidone attenuates choline-deficient, l-amino acid-defined, high-fat diet-induced metabolic dysfunction-associated steatohepatitis in mice

  2025cites this paper
• Gallstone Physicochemical Properties and Heavy Metal Concentrations Associated with Gallbladder Carcinogenesis in Assam, India.

  2025cites this paper
• Composition, Influencing Factors, and Effects on Host Nutrient Metabolism of Fungi in Gastrointestinal Tract of Monogastric Animals

  2025cites this paper
• Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction

  2025cites this paper
• Evaluation of FXR Activity in Pollutants Identified in Sewage Sludge and Subsequent in Vitro and in Vivo Characterization of Metabolic Effects of Triphenyl Phosphate

  2025cites this paper
• Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)

  2025cites this paper
• Yinzhihuang formula modulates the microbe‒gut‒liver axis and bile acid excretion to attenuate cholestatic liver injury.

  2025cites this paper
• Bilirubin Metabolism Does Not Influence Serum Bile Acid Profiles According to LC–MS: A Human Case-Control Study

  2025influential citation
• Intrahepatic cholestasis of pregnancy: A case report

  2025cites this paper
• Gut microbiota-derived UDCA enhanced by metformin inhibits FXR to activate autophagy against MCD diet-induced NAFLD in mice.

  2025cites this paper
• Research Progress on Anti-Hyperlipidemia Peptides Derived from Foods

  2025cites this paper
• Bellidifolin, a constituent from edible Mongolic Liver Tea (Swertia diluta), promotes lipid metabolism by regulating intestinal microbiota and bile acid metabolism in mice during high fat diet-induced obesity

  2025cites this paper
• The adaptive mechanism of Ctenopharyngodon idellus to dietary lipid levels: Insights from microbiota-mediated bile acid enterohepatic circulation

  2025cites this paper
• A perspective on thrombogenesis through gut microbiota-derived bile acids and platelet activation

  2025cites this paper
• Dietary bile acids reduced ferroptosis, improved the flesh quality and intestinal health of Pacific white shrimp (Litopenaeus vannamei) fed the high plant protein-based diets

  2025cites this paper
• Common misconceptions and controversies in the management of irritable bowel syndrome

  2025cites this paper
• Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications.

  2025cites this paper
• Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5

  2025cites this paper
• Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Modulation of Bile Acids and Farnesoid X Receptor by Dietary Polysaccharides: Critical Roles in Health and Disease

  2025cites this paper
• Early diagnosis of the Need for surgical drainage in chronic pancreatitis patients based on serum metabolomics.

  2025cites this paper
• Protective Effect of Obeticholic Acid on Sepsis-Induced Liver Dysfunction via Regulating Bile Acid Homeostasis

  2025cites this paper
• Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization

  2025cites this paper
• The liver-gut axis perspective: Exploring the pathogenesis of fatty liver.

  2025cites this paper
• Directed Evolution of Transcriptional Factor BreR for Improved Substrate Specificity Toward Deoxycholic Acid and Ursodeoxycholic Acid

  2025cites this paper
• Mung Bean Protein Improves Hepatic Metabolic Homeostasis via Gut Microbiota Remodeling

  2025cites this paper
• The defense role of luteolin-β-CD-MOF against acetaminophen induced liver toxicity by regulating of bile acids metabolism and gut microbiota.

  2025cites this paper
• Mechanisms of Lushi Runzao decoction in Treating Sjögren’s syndrome by remodeling gut flora to regulate bile acid and short-chain fatty acid metabolism

  2025influential citation
• Microbiota-dependent metabolites – New engine for T cell warriors

  2025cites this paper
• Advances of exosome regulating-FXR to repair inflammatory bowel disease (Review)

  2025cites this paper
• Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis

  2025cites this paper
• Burgeoning momentum: the present and future of hyodeoxycholic acid in host microbiome dynamics.

  2025cites this paper
• Bi-Directional Relationship Between Bile Acids (BAs) and Gut Microbiota (GM): UDCA/TUDCA, Probiotics, and Dietary Interventions in Elderly People

  2025cites this paper